Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Hyderabad gears up for Pulse Polio drive on November 22, targets 5.22 lakh children

The Hyderabad-based pediatrician Dr Sivaranjani Santosh, along with Access to Medicines India, has managed to bring down the cost of a rare disease drug by ₹6.5 lakh, ensuring that seven children with a severe genetic disorder can now receive the treatment they need. These children, diagnosed with Allan-Herndon-Dudley syndrome (AHDS), would have previously had to pay an exorbitant price for the drug, which could cost anywhere between ₹4.68 crore to ₹9 crore per child annually.

The drug, tiratricol or TRIAC, is now being provided to the children for free, thanks to pharmaceutical compounding in the Netherlands. The compounded version costs just ₹2.5 lakh per child for a year, a drastic reduction from its commercial price. This medicine was prepared by Transvaal Pharmacy in The Hague, in collaboration with the Netherlands-based Pharmaceutical Accountability Foundation (PAF).

After Dr Sivaranjani's child, Arav, was diagnosed with AHDS, she began her mission to make the medication accessible to others. Her social media outreach led to the involvement of PAF, which in turn engaged Transvaal Pharmacy to compound the medicine. The initiative has been successful, with the first batch of the compounded medicine set to be delivered to the parents of the seven children on November 30.

However, while this is a triumph for the seven children and their families, Dr Sivaranjani has expressed her hope to see the medicine compounded in India, making it accessible to more children with this rare genetic disorder.

Rewritten by urgent.news; may contain errors — check the original.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at thehindu.com →

Report a problem with this story

More in Health & Medicine

Virginia child dies in state’s first measles-associated death of 2026

Death adds to national measles outbreak that recently cost the US its measles elimination status after 26 years Virginia reported its first measles-associated death of 2026 on Friday, involving a child who tested positive for the infectious disease, the state’s health department said. The department said the child was age four or younger.

More from Saturday 21 November →